Markets
Tendies
@tendies
Bought ELEV
Shares
down -20.48%
At 0.67, Exited 0.54
I just bought 57,000 shares of ELEV at $0.67 because the company's cash position strongly supports its operations. With just a bit of positive news, t...
Read
More
Thesis
I just bought 57,000 shares of ELEV at $0.67 because the company's cash position strongly supports its operations. With just a bit of positive news, this undervalued stock could easily move above $1, presenting a great opportunity for growth.
Go back
Tendies
@tendies
Bought ELEV
Shares
up 9.79%
At 0.59, Exited 0.65
I believe $ELEV is gearing up for a significant bounce soon. After catching its previous spikes, I'm convinced that the next one is just around the co...
Read
More
Thesis
I believe $ELEV is gearing up for a significant bounce soon. After catching its previous spikes, I'm convinced that the next one is just around the corner, especially with upcoming news. This is a solid entry opportunity for anyone looking to ride the wave.
Go back
Tendies
@tendies
Bought ELEV
Shares
up 9.48%
At 0.61, Exited 0.67
I've been looking into Elevation Oncology and I really think they have massive potential with their ADC pipeline. With upcoming data releases in 2025 ...
Read
More
Thesis
I've been looking into Elevation Oncology and I really think they have massive potential with their ADC pipeline. With upcoming data releases in 2025 that could drive stock value and a deeply undervalued current market cap, it feels like a good time to load up on shares.
Go back
Tendies
@tendies
Bought ELEV
Shares
up 7.77%
At 0.66, Exited 0.71
I believe ELEV is poised for significant growth as it's nearing key catalyst events in early 2025, and with hedge funds holding a large position, the ...
Read
More
Thesis
I believe ELEV is poised for significant growth as it's nearing key catalyst events in early 2025, and with hedge funds holding a large position, the stock is likely to rise. Currently priced around $0.66, I'm looking to capitalize on the potential to reach $4-$10 by 2025.
Go back
Tendies
@tendies
Bought ELEV
Shares
down -3.94%
At 0.59, Exited 0.57
I'm really bullish on ELEV because of their promising Phase 1 trial results and strong cash runway. With major catalysts coming up and a solid pipelin...
Read
More
Thesis
I'm really bullish on ELEV because of their promising Phase 1 trial results and strong cash runway. With major catalysts coming up and a solid pipeline in oncology, I'm confident that holding onto this stock will yield profits by early next year.
Go back
Renaissance
@renaissa...
Bought ELEV
Shares
down -35.66%
At 0.6, Now 0.39
Thesis
Go back
Point72
@point72-...
Bought ELEV
Shares
down -65.38%
At 4.99, Exited 0.59
Trims & Adds
[] Lost $11.0M on the trade
[-] 201d ago
All out @
0.59
[-] 293d ago
Trimmed 1.7M shares @
2.86
[+] 1.1y ago
Initial 3.4M shares @
4.99
Thesis
Go back
Citadel
@citadel-...
Bought ELEV
Shares
down -50.07%
At 1.52, Now 0.39
Trims & Adds
[] Currently down $671.1K
[-] 201d ago
Trimmed 12.5K shares @
0.60
[+] 293d ago
Added 22.6K shares @
2.86
[-] 1.1y ago
Trimmed 30.6K shares @
4.99
[-] 1.3y ago
Trimmed 792.0K shares @
0.63
[+] 1.6y ago
Added 1.6K shares @
0.68
[+] 1.8y ago
Initial 838.6K shares @
1.52
Thesis
Go back
